Why the study?
Does pulmonary artery catheterisation provide clinical benefits that outweigh its risks in patients having cardiac or vascular surgery?
Does pulmonary artery catheterisation provide clinical benefits that outweigh its risks in patients having cardiac or vascular surgery?
Pulmonary artery catheterisation provides valuable hemodynamic data that alters management in a significant proportion of cardiac and vascular surgery patients, with an acceptable safety profile.
Answers are grounded in this paper and cite their sources.
May support pre-induction hemodynamic adjustments in cardiac and vascular surgery; leaves open net benefit versus risks without randomized data.
The benefits and risks of pulmonary artery catheterisation were assessed in 220 patients having cardiac or vascular surgery. Prior to induction of anaesthesia 20% of patients had pulmonary artery wedge pressure measurements which indicated the need for blood volume support, vasodilator therapy or modification of the anaesthetic induction technique. Of those patients for cardiac surgery, 38% had important changes before cardiopulmonary bypass requiring blood volume support or vasodilator therapy. These changes were not reflected by similar changes in the central venous pressure. The risks of the technique were minimal. Minor complications occurred in 25% of patients (transient arrhythmias) and more serious complications occurred in 3.6% of patients. There was no mortality or long-term sequelae. We conclude that the benefits of pulmonary artery catheterisation outweigh its risks in patients having major cardiac and vascular surgery.
No takes yet. Share an insight, caveat, or question.
Davies et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: